A Genotype-Guided Strategy for Oral P2Y(12) Inhibitors in Primary PCI

Daniel M. F. Claassens, Gerrit J. A. Vos, Thomas O. Bergmeijer, Renicus S. Hermanides, Arnoud W. J. van 't Hof, Pim van der Harst, Emanuele Barbato, Carmine Morisco, Richard M. Tjon Joe Gin, Folkert W. Asselbergs, Arend Mosterd, Jean-Paul R. Herrman, Willem J. M. Dewilde, Paul W. A. Janssen, Johannes C. Kelder, Maarten J. Postma, Anthonius de Boer, Cornelis Boersma, Vera H. M. Deneer, Jurrien M. ten Berg*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1621-1631
Number of pages11
JournalNew England Journal of Medicine
Volume381
Issue number17
DOIs
Publication statusPublished - 24 Oct 2019

Keywords

  • PERCUTANEOUS CORONARY INTERVENTION
  • ELEVATION MYOCARDIAL-INFARCTION
  • DUAL ANTIPLATELET THERAPY
  • ST-SEGMENT ELEVATION
  • CYP2C19 GENOTYPE
  • STENT THROMBOSIS
  • OPEN-LABEL
  • CLOPIDOGREL
  • OUTCOMES
  • MULTICENTER

Cite this

Claassens, D. M. F., Vos, G. J. A., Bergmeijer, T. O., Hermanides, R. S., van 't Hof, A. W. J., van der Harst, P., Barbato, E., Morisco, C., Gin, R. M. T. J., Asselbergs, F. W., Mosterd, A., Herrman, J-P. R., Dewilde, W. J. M., Janssen, P. W. A., Kelder, J. C., Postma, M. J., de Boer, A., Boersma, C., Deneer, V. H. M., & ten Berg, J. M. (2019). A Genotype-Guided Strategy for Oral P2Y(12) Inhibitors in Primary PCI. New England Journal of Medicine, 381(17), 1621-1631. https://doi.org/10.1056/NEJMoa1907096